MicroRNA-181 inhibits glioma cell proliferation by targeting cyclin B1
Authors:
- 28 July 2014
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 10 (4) , 2160-2164
Abstract
Small non‑coding RNAs from the microRNA family (miRs) are important elements in the posttranscriptional control of gene expression. miRs are known to regulate numerous cellular processes and are of crucial importance during development and in pathological conditions, including tumor initiation and progression. In the present study, the expression level of miR‑181 was reduced in glioma tissues compared with the adjacent normal tissues. The enforced expression of miR‑181 was able to inhibit cell proliferation in U251 and SHG‑44 cells, while antisense miR‑181 oligonucleotides (antisense miR‑181) enhanced cell proliferation. At the molecular level, these results further revealed that the expression of cyclin B1, a positive cell‑cycle regulator, was negatively regulated by miR‑181. Therefore, the data reported in the present study demonstrates that miR‑181 is an important regulator in glioma. These results may contribute to improving the understanding of the key misregulated miRNAs in glioma.Keywords
This publication has 19 references indexed in Scilit:
- Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cellsCellular Signalling, 2013
- Understanding high grade glioma: Molecular mechanism, therapy and comprehensive managementCancer Letters, 2013
- Predictors of Long-Term Survival in Patients With Glioblastoma Multiforme: Advancements From the Last Quarter CenturyCancer Investigation, 2013
- Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted?British Journal of Cancer, 2013
- Current Status of Immunotherapy and Gene Therapy for High-Grade GliomasCancer Control, 2013
- MicroRNA profiling: approaches and considerationsNature Reviews Genetics, 2012
- MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapyNature Reviews Cancer, 2011
- miRNA signature associated with outcome of gastric cancer patients following chemotherapyBMC Medical Genomics, 2011
- Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by miR-29 and miR-181Cancer Research, 2006
- The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiationNature Cell Biology, 2006